Guillet; Jean-Gerard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Guillet; Jean-Gerard.The latest application filed is for "phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologies".

Company Profile

0.10.11

Guillet; Jean-Gerard - Paris FR
Guillet; Jean-Gerard - Vanves FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines Grant 8,932,599 - Guillet , et al. January 13, 2	2015-01-13
Phosphorylated Derivatives Of A U1-70k Peptide And Their Use In The Treatment Of Autoimmune Pathologies App 20140004136 - Muller; Sylviane ; et al.	2014-01-02
Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Grant 8,475,800 - Muller , et al. July 2, 2	2013-07-02
Use Of Peptides Comprising Post-translational Modifications In The Treatment Of Autoimmune Pathologies App 20120149652 - MULLER; Sylviane ; et al.	2012-06-14
Synthetic Gene Construct Coding for an HIV1 GAG and Use Thereof for Obtaining Anti-HIV-1 Vaccines App 20110171250 - Guillet; Jean-Gerard ; et al.	2011-07-14
Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies Grant 7,872,098 - Muller , et al. January 18, 2	2011-01-18
Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof App 20100203080 - Maillere; Bernard ; et al.	2010-08-12
Modified Peptides and Their Use for the Treatment of Autoimmune Diseases App 20100047333 - MULLER; SYLVIANE ; et al.	2010-02-25
Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereof Grant 7,488,791 - Maillere , et al. February 10, 2	2009-02-10
Mixed lipopeptide micelles for inducing an immune response Grant 7,476,386 - Gras-Masse , et al. January 13, 2	2009-01-13
Polyepitopic Protein Fragments Of The E6 And E7 Proteins Of Hpv, Their Production And Their Use Particularly In Vaccination App 20080248044 - Choppin; Jeannine ; et al.	2008-10-09
Cellular Immunity Test With Peptides Attached To A Solid Support App 20080213818 - GAHERY-SEGARD; Hanne ; et al.	2008-09-04
Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination Grant 7,288,258 - Choppin , et al. October 30, 2	2007-10-30
Cellular immunity test with peptides fixed on a solid support App 20060121537 - Gahery-Segard; Hanne ; et al.	2006-06-08
Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination App 20050033025 - Choppin, Jeannine ; et al.	2005-02-10
Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof App 20040170644 - Mailere, Bernard ; et al.	2004-09-02
Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines Grant 6,783,763 - Choppin , et al. August 31, 2	2004-08-31
Mixture of peptides originating from a Nef protein and applications thereof App 20040115622 - Maillere, Bernard ; et al.	2004-06-17
Lipopeptides containing an interferon-.gamma. fragment, and uses thereof in pharmaceutical compositions Grant 6,683,052 - Thiam , et al. January 27, 2	2004-01-27
Apparatus and process for the detection and counting of rarely occurring mammalian cells Grant 5,751,839 - Drocourt , et al. May 12, 1	1998-05-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.